Length of Stay and Complications in High-risk Patients Receiving Fast-track Total Hip (THA) or Knee- Alloplasty (TKA)
Study Details
Study Description
Brief Summary
The purpose of the study is to determine the influence of preoperative co-morbidity in relation to increased length of stay and postoperative complications in patients receiving fast-track hip or knee replacement.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Preoperative risk assessment is well established and repeatedly demonstrated to be related to adverse postoperative outcomes regarding all organ functions. However, all evidence is based upon conventional care programs and none has been done on fast-track surgery, neither in total hip arthroplasty (THA) or total knee arthroplasty (TKA).
The purpose of this study series is therefore to evaluate the importance of conventional risk factors in an optimised fast-track TKA and THA set-up. These studies will be performed in the Lundbeck Foundation Center for fast-track THA and TKA, based on an established database, but with additional detailed risk information to be included in studies of certain types co-morbidity.
The Lundbeck Foundation Center Database prospectively registers patient characteristics and co-morbidity in all patients receiving hip and knee arthroplasty. This is done using a questionaire and with dedicated staff available to help in case of doubt regarding specific questions. Additional information is collected by scrutinizing the patients medical charts. Completeness of data has been shown to be about 95%.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Fast-track THA/TKA Any patient receiving THA/TKA in the participating wards |
Outcome Measures
Primary Outcome Measures
- Length of hospital stay and reasons for length of hospital stay >4days [At discharge]
Number of nights spend in hospital after day of surgery, including transferral between departments. Any procedure followed by more than 4 days in hospital will have review of discharge papers to determine causes of the "prolonged" admission
- Surgically related readmissions [90 days after surgery]
Evaluation of any potentially surgery related readmission 90 days after discharge. Readmissions defined as related are defined as: Revision due to prosthesis problems, deep venous thrombosis (DVT), pulmonary embolism (PE) (verified or disproved), stroke/transitory cerebral ischaemia (TCI), possible wound infection (return to operating theatre, treatment with antibiotics only, no treatment), fractures without known trauma, falls, knee manipulation, hip dislocation, cardiac problems (acute myocardial infarction (AMI), any type of arrhythmia), pneumonia, urinary retention (UR), abdominal complications (gastric ulcer, ileus) and sequelae (rehabilitation, opioid side-effects, pain, other conditions related to surgery). Readmissions due to chronic obstructive lung disease (COPD), syncope and urinary tract infection (UTI) ≤ 30 days of primary admission
Secondary Outcome Measures
- Mortality 90 days after surgery [90 days after surgery]
Evaluation of all deaths 90 days after surgery
Other Outcome Measures
- Co-morbidity related readmissions [90 days after surgery]
Depending on the type of co-morbidity investigated, special attention and analysis of readmissions found to be related to the specific type of co-morbidity will be done
Eligibility Criteria
Criteria
Inclusion Criteria:
- Standardized elective fast-track THA or TKA
Exclusion Criteria:
-
Elective THA or TKA not in regular fast-track setup
-
not a Danish citizen
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Himmerland Hospital | Farsø | Judland | Denmark | 9640 |
2 | Holstebro Regionalhospital | Holstebro | Judland | Denmark | 7500 |
3 | Vejle Hospital | Vejle | Judland | Denmark | 7100 |
4 | Hvidovre Hospital | Hvidovre | Seeland | Denmark | 2650 |
5 | Bispebjerg University Hospital | Copenhagen | Denmark | ||
6 | Gentofte University Hospital | Gentofte | Denmark | ||
7 | Næstved Hospital | Næstved | Denmark |
Sponsors and Collaborators
- Rigshospitalet, Denmark
- Hvidovre University Hospital
- Aarhus University Hospital
- Vejle Hospital
- Sydvestjysk Hospital
- Regional Hospital Holstebro
- Naestved Hospital
- Bispebjerg Hospital
- Central Jutland Regional Hospital
- Aalborg University Hospital
Investigators
- Principal Investigator: Christoffer C Joergensen, MD, Rigshospitalet, Denmark
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- RH30-0623